ArticleScientific reports2024
Stage-based colorectal cancer prediction on uncertain dataset using rough computing and LSTM models.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A synthetic oversampling-based customized ResNet51-Conv1D framework for early colorectal cancer prediction using structured clinical data from the PLCO screening trial.BMC medical informatics and decision making · 2026Article
- A multi-model prediction of a stage-specific prognosis for colorectal cancer using attention-driven deep ensemble learning on genomic profiling data.Frontiers in artificial intelligence · 2026Article
- Gamma-Glutamyl Transferase Plus Carcinoembryonic Antigen Ratio Index: A Promising Biomarker Associated with Treatment Response to Neoadjuvant Chemotherapy for Patients with Colorectal Cancer Liver Metastases.Current oncology (Toronto, Ont.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial intelligence (AI) is an attractive field of Computer Science that helps to classify and to predict various real-time applications. Perhaps AI has a major role in predicting diseases at an early stage based on history. As cancer is one of the most harmful diseases where the mortality rate is high, it is now essential to utilize the benefits of AI to have an early diagnosis of cancer. Among various cancers, Colorectal cancer (CRC) is a common form of gastrointestinal cancer, and its treatment is lengthy and costly, with a high recurrence rate and high fatality rate. Initial disease analysis and prognosis are required to improve the patient's treatment with a better survival analysis. However, the disease prediction process depends on the collected data, where the data may contain uncertainty. Uncertain data leads to wrong predictions. Thus, it is essential to utilize rough computing, a mathematical tool to deal with uncertainty. This paper has made an effort, to handle uncertainty using a rough set of fuzzy approximation space as pre-processing and utilized Unidirectional and Bidirectional LSTM for the classification and prediction process. Thus, to demonstrate improved predictive accuracy, the proposed model adapted the optimizers and evaluated using benchmarking techniques in predicting stage-based survival rate. The comparative analysis shows that the proposed model performs well against the state-of-the-art models and can help the medical practitioner to detect CRC at an early stage and reduce the mortality rate among human beings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.